$16MSeries A, 31 March 2026
Series A to accelerate development of protein-based products with ScalaOS
- Amount
- $16M
- Stage
- Series A
- Announced
- 31 March 2026
- Use of funds
- Series A to accelerate development of protein-based products with ScalaOS
- Checked
- Announced by the company
- Sources
- Scala Biodesign raises $16M Series A pulse2.com
Scala Biodesign raises $16M Series A pulse2.com